{"id":2442,"date":"2025-01-15T16:01:43","date_gmt":"2025-01-15T13:01:43","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=2442"},"modified":"2025-03-07T14:57:03","modified_gmt":"2025-03-07T11:57:03","slug":"3-drugs-receiving-accelerated-approval-from-the-fda-and-reviewed-by-the-office-of-inspector-general-raised-concerns","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/de\/3-drugs-receiving-accelerated-approval-from-the-fda-and-reviewed-by-the-office-of-inspector-general-raised-concerns\/","title":{"rendered":"3 Medikamente, die eine beschleunigte Zulassung durch das FDA erhielten und vom B\u00fcro des Generalinspektors gepr\u00fcft wurden, gaben Anlass zur Sorge"},"content":{"rendered":"<p class=\"wp-block-paragraph\">Trotz zweifelhafter Beweise und Meinungsverschiedenheiten zwischen den Pr\u00fcfern hat die US-amerikanische Food and Drug Administration Aduhelm von Biogen, Exondys 51 (Eteplirsen) von Sarepta und Makena von Covis Pharma schnell zugelassen, berichtete das B\u00fcro des Generalinspektors des Gesundheitsministeriums am Dienstag. Die Analyse ergab, dass in einem Fall wichtige Entscheidungen nicht dokumentiert waren.<\/p>","protected":false},"excerpt":{"rendered":"<p>Trotz zweifelhafter Beweise und Meinungsverschiedenheiten zwischen den Pr\u00fcfern hat die US-amerikanische Food and Drug Administration Aduhelm von Biogen, Exondys 51 (Eteplirsen) von Sarepta und Makena von Covis Pharma schnell zugelassen, berichtete das B\u00fcro des Generalinspektors des Gesundheitsministeriums am Dienstag. Die Analyse ergab, dass in einem Fall wichtige Entscheidungen nicht dokumentiert waren.<\/p>","protected":false},"author":1,"featured_media":2444,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[281],"tags":[119,120,88,162,65],"class_list":["post-2442","post","type-post","status-publish","format-standard","has-post-thumbnail","category-press-releases","tag-eteplirsen","tag-exondys-51","tag-fda","tag-office-of-inspector-general","tag-sarepta"],"_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/posts\/2442","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/comments?post=2442"}],"version-history":[{"count":0,"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/posts\/2442\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/media\/2444"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/media?parent=2442"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/categories?post=2442"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/tags?post=2442"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}